{"schema_version":"secwatch.filing_event.v1","accession":"0001658247-26-000020","form_type":"8-K","ticker":"CRNX","cik":"0001658247","company_name":"Crinetics Pharmaceuticals, Inc.","filed_at":"2026-03-23T23:59:59+00:00","discovered_at":"2026-05-14T18:02:35.788273+00:00","generated_at":"2026-05-15T09:22:21.704902+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Crinetics' Chief Development and Operating Officer resigns effective April 10, 2026","bullets":["Jeff Knight resigns as Chief Development and Operating Officer, effective April 10, 2026.","Resignation is to pursue another opportunity; not related to any disagreement with the Company.","No successor named; Knight's duties and direct reports reassigned to other executive leadership team members."],"urls":{"canonical":"https://secwatch.observer/filing/0001658247-26-000020","json":"https://secwatch.observer/filing/0001658247-26-000020.json","markdown":"https://secwatch.observer/filing/0001658247-26-000020.md","text":"https://secwatch.observer/filing/0001658247-26-000020.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1658247/000165824726000020/0001658247-26-000020-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1658247/000165824726000020/crnx-20260317.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T09:22:21.704902+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}